Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.55 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.55 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.54 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.54 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CETP | P11597 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL594176 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL308645 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL16389868 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL15281949 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL10600706 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL875221 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8627798 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL308262 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8623658 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL308684 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1040 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4694699-A2 | COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY | VitaKey Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4665327-A1 | COMPOSITIONS COMPRISING 3,4-METHYLENEDIOXYMETHAMPHETAMINE, OPTIONALLY IN COMBINATION WITH N-ACYLETHANOLAMINES, AND USES THEREOF | Clearmind Labs Corp. (CA) | 2025-12-24 | — | — | EP | claimed |
| EP-4665348-A1 | COMPOSITIONS COMPRISING IBOGAINE, OPTIONALLY IN COMBINATION WITH N-ACYLETHANOLAMINES, AND USES THEREOF | Clearmind Labs Corp. (CA) | 2025-12-24 | — | — | EP | claimed |
| EP-4665317-A1 | COMPOSITIONS COMPRISING KETAMINE, OPTIONALLY IN COMBINATION WITH N-ACYLETHANOLAMINES, AND USES THEREOF | Clearmind Labs Corp. (CA) | 2025-12-24 | — | — | EP | claimed |
| EP-4661877-A1 | COMPOSITIONS COMPRISING PSILOCYBIN, OPTIONALLY IN COMBINATION WITH N-ACYLETHANOLAMINES AND USES THEREOF | Clearmind Labs Corp. (CA) | 2025-12-17 | — | — | EP | claimed |
| US-20250302773-A1 | COMPOSITIONS COMPRISING MEAI AND N-ACYLETHANOLAMINES AND USES THEREOF | Clearmind Medicine Inc. (CA) | 2025-10-02 | — | — | US | claimed |
| US-12239634-B2 | Methods of treating pruritus | CLEXIO BIOSCIENCES LTD. (IL) | 2025-03-04 | — | — | US | claimed |
| WO-2024216228-A2 | COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY | VITAKEY INC. (US) | 2024-10-17 | — | — | WO | claimed |
| WO-2024171074-A1 | COMPOSITIONS COMPRISING KETAMINE, OPTIONALLY IN COMBINATION WITH N-ACYLETHANOLAMINES, AND USES THEREOF | Clearmind Medicine Inc. (IL) | 2024-08-22 | — | — | WO | claimed |
| WO-2024171075-A1 | COMPOSITIONS COMPRISING IBOGAINE, OPTIONALLY IN COMBINATION WITH N-ACYLETHANOLAMINES, AND USES THEREOF | Clearmind Medicine Inc. (IL) | 2024-08-22 | — | — | WO | claimed |
| WO-2008023998-A1 | N-ACYLETHANOLAMINES AS WOUND HEALING AGENTS | INDUSTRIAL RESEARCH LIMITED (NZ) | 2008-02-28 | — | — | WO | claimed |
| US-20070270496-A1 | Pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system | EPITECH GROUP S.R.L. (IT) | 2007-11-22 | — | — | US | claimed |
| EP-1844784-A1 | A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system | Epitech Group S.r.l. (IT) | 2007-10-17 | — | — | EP | claimed |
| US-7199082-B1 | Composition of an N-acylethanolamine plant hormone of an auxin, a gibberellin or a cytokinin; and a horticulturally-acceptable vehicle; treating and storing cut flowers, Christmas trees, fruits, and other severed plant parts | UNIVERSITY OF NORTH TEXAS (US) | 2007-04-03 | — | — | US | claimed |
| EP-1263286-B1 | METHODS FOR EXTENDING THE FRESHNESS OF CUT FLOWERS | UNIV NORTH TEXAS (US) | 2006-02-22 | — | — | EP | claimed |
| US-20050081311-A1 | Pearly-lustre coloring agents for keratin fibers | WELLA AKTIENGESELLSCHAFT (DE) | 2005-04-21 | — | — | US | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4777038-A | NONIONIC, STORAGE-STABLE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1988-10-11 | — | — | US | claimed |
| US-4312771-A | POTASSIUM SALTS OF FATTY ACIDS, FATTY ACID MONOETHANOLAMIDE, AND PROPANEDIOL OR GLYCEROL | DUSKIN FRANCHISE CO., LTD. (JP) | 1982-01-26 | — | — | US | claimed |
| US-4039562-A | MALEIC ANHYDRIDE, FATTY ALCOHOL, ALKALI METAL SULFITE | REWO CHEMISCHE WERKE G.M.B.H. (DT) | 1977-08-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050081311-A1 | Pearly-lustre coloring agents for keratin fibers | KRT18, AKR7A2, ELOVL5 | FAAH 496/4885MEN1 4633/4885KMT2A 387/4885 |
| US-20250302773-A1 | COMPOSITIONS COMPRISING MEAI AND N-ACYLETHANOLAMINES AND USES THEREOF | SLC18A2, PNMT, DBI | FAAH 83/4885MEN1 886/4885KMT2A 221/4885 |
| US-20070270496-A1 | Pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system | HCAR2, HCAR1, MYD88 | FAAH 329/4885MEN1 1658/4885KMT2A 3832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.